Order Article Reprints

Lachance S, Christofides AL, Lee JK, Sehn LH, Ritchie BC, Shustik C, Stewart DA, Toze CL, Haddad E, Vinh DC. A Canadian Perspective on the Use of Immunoglobulin Therapy to Reduce Infectious Complications in Chronic Lymphocytic Leukemia. Current Oncology. 2016; 23(1):42-51. https://doi.org/10.3747/co.23.2810

Lachance, S., A.L. Christofides, J.K. Lee, L.H. Sehn, B.C. Ritchie, C. Shustik, D.A. Stewart, C.L. Toze, E. Haddad, and D.C. Vinh. 2016. "A Canadian Perspective on the Use of Immunoglobulin Therapy to Reduce Infectious Complications in Chronic Lymphocytic Leukemia" Current Oncology 23, no. 1: 42-51. https://doi.org/10.3747/co.23.2810

Lachance, S., Christofides, A. L., Lee, J. K., Sehn, L. H., Ritchie, B. C., Shustik, C., Stewart, D. A., Toze, C. L., Haddad, E., & Vinh, D. C. (2016). A Canadian Perspective on the Use of Immunoglobulin Therapy to Reduce Infectious Complications in Chronic Lymphocytic Leukemia. Current Oncology, 23(1), 42-51. https://doi.org/10.3747/co.23.2810